GWP.L Regulatory News (GWP)

BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED COMPANY SHARE OPTION SCHEME

3. PERIOD OF RETURN:

FROM: 1 NOVEMBER 2009 TO: 17 FEBRUARY 2011

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

145,400 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

67,500 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

77,900 ORDINARY SHARES OF 0.1P EACH

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

507,146 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

131,549,592 ORDINARY SHARES OF 0.1P EACH

BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001

3. PERIOD OF RETURN:

FROM: 01 NOVEMBER 2009 TO: 17 FEBRUARY 2011

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

384,958 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

102,000 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

282,958 ORDINARY SHARES OF 0.1P EACH

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

131,549,592 ORDINARY SHARES OF 0.1P EACH

BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001

3. PERIOD OF RETURN:

FROM: 01 NOVEMBER 2009 TO: 17 FEBRUARY 2011

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

1,276,492 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

657,833 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

618,659 ORDINARY SHARES OF 0.1P EACH

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

131,549,592 ORDINARY SHARES OF 0.1P EACH

BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME

3. PERIOD OF RETURN:

FROM: 1 NOVEMBER 2009 TO: 17 FEBRUARY 2011

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

212,612 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

212,612 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

NIL ORDINARY SHARES OF 0.1P EACH.

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003

300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008

400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

131,549,592 ORDINARY SHARES OF 0.1P EACH

For further information, please contact:

Adam George, Company Secretary, GW Pharmaceuticals plc

Telephone: +44 (0)1980 557000

James Steel/Vijay Barathan, Nominated Adviser, Peel Hunt LLP

Telephone: +44 (0)20 7418 8900